XML 50 R2.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Income - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Revenues and other income:    
Sales and other operating revenues $ 25,215 $ 28,253
Income (loss) from equity method investments (1,210) [1],[2] 99
Net gain on disposal of assets 4 214
Other income 71 35
Total revenues and other income 24,080 28,601
Costs and expenses:    
Cost of revenues (excludes items below) 22,821 25,960
Inventory market valuation adjustment 3,220 0
Impairment expense 7,822 0
Depreciation and amortization 962 919
Selling, general and administrative expenses 821 867
Other taxes 251 186
Total costs and expenses 35,897 27,932
Income (loss) from operations (11,817) 669
Net interest and other financial costs 338 306
Income (loss) before income taxes (12,155) 363
Provision (benefit) for income taxes (1,937) 104
Net income (loss) (10,218) 259
Less net income (loss) attributable to:    
Redeemable noncontrolling interest 20 20
Noncontrolling interests (1,004) 246
Net loss attributable to MPC $ (9,234) $ (7)
Basic:    
Net loss attributable to MPC per share $ (14.25) $ (0.01)
Weighted average shares outstanding (in shares) 648 673
Diluted:    
Net loss attributable to MPC per share $ (14.25) $ (0.01)
Weighted average shares outstanding (in shares) 648 673
[1]
The 2020 period includes $1,315 million of impairment expense. See Note 4 for further information.

[2] The 2020 period includes $1,315 million of impairment expense. See Note 4 for further information.